Moving Forward

Sanarus established its leadership in minimally invasive breast care by providing physicians and patients with cryoablation-based alternatives to surgery. Our strategy moving forward is to continue developing and expanding the network of breast care specialists who offer cryoablation-based treatment and to facilitate access to cryoablation treatment for patients. 

Expanding the use of cryoablation in breast care 

Currently, Sanarus offers a line of products for breast care that includes the ImarC™ Tissue Markers and the Visica 2™ Treatment System for cryoablation of fibroadenomas. One of our priorities is to expand the use of cryoablation into other treatment areas, including the treatment of cancer, thereby providing physicians and patients with a comprehensive range of minimally invasive treatment options for the treatment of breast tumors.